Proactive Investors - Run By Investors For Investors

Opsepio Therapeutics looks to raise $30mln for its Phase 1 ready cancer treatment

Opsepio Therapeutics Inc CEO Michael Stocum talks to Proactive Investors at the 11th Annual Biotech Showcase in San Francisco.

The company has identified a molecule to treat all kinds of cancers, and is looking to develop it into Phase 1 early summer. Stocum says the company is looking to raise $30mln to take the company through clinical studies.

View full PROAC profile View Profile

Proactiveinvestors Timeline

Copyright ©, 2019. All Rights Reserved - Proactive Investors North America Inc., Proactive Investors LLC

Market Indices, Commodities and Regulatory News Headlines copyright © Morningstar. Data delayed 15 minutes unless otherwise indicated. Terms of use